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Background 
Direct-acting antivirals (DAAs) for HCV treatment achieve high success rates, but are 
more likely to select for viral drug-resistant mutants. They can emerge during the 
course of treatment, but can also occur as pre-existing polymorphisms. Combination 
therapy strategies with DAAs targeting different viral proteins are used to tackle drug 
resistance development. In order to detect resistance mutations simultaneously in all 
viral target genes under selective pressure of a combination therapy, we developed a 
full-genome sequencing strategy. Both population and next-generation sequencing 
(NGS) were performed, with the latter more trustworthy to detect minority variants 
at levels below 20%. The analysis of NGS data from heterogeneous viral populations 
such as hepatitis C virus remains a non-trivial exercise. In order to accommodate the 
specific characteristics of short read fragment data derived from such diverse 
populations, we studied the impact of tailored analysis methodologies and of 
reference sequence divergence on the recovery of minority variants. 
Material and methods 
Four samples from treatment-naïve HCV1b infected patients were amplified by nested 
PCR and sequenced with Illumina’s Genome Analyzer IIx. The performance of four 
software packages (MAQ, Bowtie, BWA and Segminator II) for aligning the Illumina 
reads against a reference sequence was tested. To assess the impact of using a related 
reference sequence, all reads of each sample were mapped to a published HCV1b 
reference sequence (GenBank: AB049087), to a consensus sequence of the respective 
sample obtained by Sanger sequencing and to an in silico reconstructed data-specific 
reference sequence (VICUNA and V-FAT). Concordance between the viral population 
obtained after Sanger sequencing and after read mapping with Segminator II using 
the three mentioned reference sequences, was compared. The observed differences 
in minority variants between the analysis with a sample-specific and a more distantly 
related sequence were compared. Positions with high difference (>5% threshold) 
were compared with the location of highly divergent regions, defined as areas with 
Shannon entropy above the 75th percentile. 
Results 
Performance of software packages to align reads to a reference sequence 
Conclusions 
Only a few software packages can accommodate the diversity present in 
heterogeneous viral populations. Using a distantly related reference sequence leads 
to substantial data losses, even with the best among the software packages, 
Segminator II. Although the image of the viral population is largely independent of 
the used reference sequence, most discordances are enriched in highly divergent 
regions. So we recommend the use of sample-/data-specific reference sequences for 
read mapping. 
Mapping the quality trimmed reads of the four samples using different software 
programs revealed that Segminator II was the best software package in recovering 
number of reads. For all software packages, the number of mapped reads was 
consistently higher when a sample-specific sequence was used instead of the 
standardly used but more divergent HCV1b reference sequence (HCV1b AB049087). 
For the second best performing program, MAQ, the protocol was optimized by using 
the HCV1b AB049087 reference to build a contig, which served as the reference in the 
next rounds of mapping (cycling option). Additionally, for the best performing 
software Segminator II, reads were mapped against an in silico data-specific reference 
sequence (VICUNA). The option in Segminator II to automatically replace the template 
with the obtained consensus sequence during mapping, was selected for the three 
reference sequences. 
For Segminator II, 80.6% (± 3.0) of the reads were mapped against the sample-
specific Sanger sequence, 77.3% (± 2.4) against the Genbank reference sequence 
and 82.1% (± 4.0) of the reads is recovered against an in silico data-specific reference 
sequence with Segminator II (VICUNA).  
Differences in minority variants: distance of reference sequence  
The main differences in minority variants between the sample-specific and more 
distantly related sequence were located below the 0.5% threshold. However, in total 
184 differences at frequencies above the 5% threshold were observed. All these 
positions were located at (70.34%) or within 5 nucleotides of a divergent area. The 
coverage of reads and the Shannon entropy  of a region are correlated inversely. 
Reference sequence Major + minor discordance (%, stdev) Major discordance (%, stdev) 
HCV1bAB049087 
(Genbank) 1,72 (+/- 0,791) 0,30 (+/- 0,092) 
Sanger sequence (sample-
specific) 1,70 (+/- 0,700) 0,026 (+/- 0,014) 
Reconstructed in silico 
reference (sample-
specific) 1,47 (+/- 0,790) 0,05 (+/- 0,024) 
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